135 related articles for article (PubMed ID: 35343088)
41. First nationwide study on driving under the influence of drugs in Switzerland.
Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
[TBL] [Abstract][Full Text] [Related]
42. User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents.
Pechansky F; Scherer JN; Schuch JB; Roglio V; Telles YM; Silvestrin R; Pasa G; Sousa T
Traffic Inj Prev; 2019; 20(1):30-36. PubMed ID: 30822144
[TBL] [Abstract][Full Text] [Related]
43. Which drugs are associated with highest risk for being arrested for driving under the influence? A case-control study.
Bogstrand ST; Gjerde H
Forensic Sci Int; 2014 Jul; 240():21-8. PubMed ID: 24814328
[TBL] [Abstract][Full Text] [Related]
44. Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015.
Lema-Atán JÁ; de Castro A; Lendoiro E; López-Rivadulla M; Cruz A
Drug Alcohol Depend; 2019 Feb; 195():106-113. PubMed ID: 30611978
[TBL] [Abstract][Full Text] [Related]
45. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
Logan BK; Mohr AL; Talpins SK
J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
[TBL] [Abstract][Full Text] [Related]
46. An evaluation of on-site oral fluid drug screening devices DrugWipe 5+ and Rapid STAT using oral fluid for confirmation analysis.
Pehrsson A; Blencowe T; Vimpari K; Langel K; Engblom C; Lillsunde P
J Anal Toxicol; 2011 May; 35(4):211-8. PubMed ID: 21513614
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
48. The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safety.
Romano E; Moore C; Kelley-Baker T; Torres-Saavedra PA
Traffic Inj Prev; 2019; 20(7):667-672. PubMed ID: 31356118
[No Abstract] [Full Text] [Related]
49. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
50. A field evaluation of five on-site drug-testing devices.
Crouch DJ; Hersch RK; Cook RF; Frank JF; Walsh JM
J Anal Toxicol; 2002 Oct; 26(7):493-9. PubMed ID: 12423006
[TBL] [Abstract][Full Text] [Related]
51. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Röhrich J; Zörntlein S; Becker J; Urban R
J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
[TBL] [Abstract][Full Text] [Related]
52. Drug driving in Italy. The results of the first roadside drug testing service utilizing on-site confirmatory analysis between 2019 and 2022.
Poetto AS; Catesini G; Dossetto P; Marchetti S; Addobbati R
Forensic Sci Int; 2024 Feb; 355():111929. PubMed ID: 38262308
[TBL] [Abstract][Full Text] [Related]
53. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
54. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.
Peters FT; Samyn N; Kraemer T; Riedel WJ; Maurer HH
Clin Chem; 2007 Apr; 53(4):702-10. PubMed ID: 17332148
[TBL] [Abstract][Full Text] [Related]
55. [Proposal of psychomotor skill assessment tests for drivers and a protocol for sampling and testing of saliva, blood and urine when there is reason to suspect involvement of substances with alcohol-like effect].
Wiergowski M; Jankowski Z; Tomczak E; Anand JS; Ziółkowski R; Staniszewski J
Arch Med Sadowej Kryminol; 2012; 62(3):186-96. PubMed ID: 23650844
[TBL] [Abstract][Full Text] [Related]
56. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
57. An evaluation of selected oral fluid point-of-collection drug-testing devices.
Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
[TBL] [Abstract][Full Text] [Related]
58. Analytical evaluation of a rapid on-site oral fluid drug test.
Goessaert AS; Pil K; Veramme J; Verstraete A
Anal Bioanal Chem; 2010 Apr; 396(7):2461-8. PubMed ID: 20140665
[TBL] [Abstract][Full Text] [Related]
59. Fluorescence-based lateral flow assays for rapid oral fluid roadside detection of cannabis use.
Plouffe BD; Murthy SK
Electrophoresis; 2017 Feb; 38(3-4):501-506. PubMed ID: 27862053
[TBL] [Abstract][Full Text] [Related]
60. A review of suspected cases of driving under the influence of drugs (DUID) involved in traffic accidents in Istanbul (Turkey).
Acar F; Asirdizer M; Aker RG; Kucukibrahimoglu EE; Ates I; Erol Y; Sahin A
J Forensic Leg Med; 2013 Aug; 20(6):626-31. PubMed ID: 23910848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
